Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Artificial Pancreas Device System (APDS) market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 
Report Description
Eating habits of type 1 diabetes patients is highly curtailed, complemented by regular administration of insulin. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. Advancements in research and technology has led to commercialization of easy-to-us insulin delivery systems such as insulin pens, pumps, inhaled insulin, and injectors. Use of syringes to deliver insulin has become obsolete with the introduction of advanced and easy-to-use insulin delivery systems mentioned above. Moreover, these systems offer the convenience to self-administer insulin at home. An artificial pancreas is a novel concept that promises to revolutionize the entire diabetes market. The system automatically detects glucose level in patient's blood or plasma and accordingly administers the necessary dosage of insulin. Medtronic's MiniMed 670G is one such wearable artificial pancreas. The system is automated to monitor glucose levels and deliver insulin through an insulin pump attached to the system. The artificial pancreas system comprises a transmitter, sensor, and insulin pump. This helps in continuous monitoring and diabetes management at ease.
Market Dynamics
The artificial pancreas device system (APDS) market growth would be mainly driven by increasing adoption of the highly useful systems the large base of diabetes type 1 patients, further supplemented by ever increasing incidence of type 1 diabetes. According to the World Health Organization (WHO), number of diabetes patients worldwide increased from 108 million in 1980 to 422 million in 2014. According to Juvenile Diabetes Research Foundation (JDRF), there were around 1.5 million type 1 diabetics worldwide in 2015. JDRF funds research in diabetes 1 and the non-profit organization expected the first artificial pancreas to be commercialized in 2017. According to the Center for Disease Control and Prevention (CDC), type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S. Developed regions are expected to dominate the artificial pancreas device system (APDS) market size, as these regions are early adopters of disruptive technologies. With the introduction of this technology, market for insulin pens and injectors is expected to be impacted negatively.
Market Taxonomy
This report segments the global artificial pancreas device system (APDS) market on the basis of technology, distribution channel, end user and geography. On the basis of technology, the global artificial pancreas device system (APDS) market is categorized into Treat to Range/Control to Range (TTR/CTR), Treat to Target/ Control to Target (TTR/CTT) and Threshold Suspended Device Systems. On the basis of distribution channel the global artificial pancreas device system (APDS) market is segmented into e-commerce, Standalone Retail Shops and hospitals. End user of the APDS include type 1 and type 2 diabetic patients. For comprehensive understanding of market dynamics, the global artificial pancreas device system (APDS) market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
• This report provides in-depth analysis of the artificial pancreas systems and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global artificial pancreas device system (APDS) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Medtronic, Medtrum, Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, and Insulet Corporation
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
• The global artificial pancreas device system (APDS) market report caters to various stakeholders in this industry, including investors, manufacturers and distributors for artificial pancreas system and components, end users, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the artificial pancreas device system (APDS) market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global Artificial Pancreas Device System (APDS) Market, By Technology:
o Threshold Suspended Device Systems
o Treat to Range/Control to Range (TTR/CTR)
o Treat to Target/ Control to Target (TTR/CTT)
• Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
o E-commerce
o Standalone Retail Shops
o Hospitals
• Global Artificial Pancreas Device System (APDS) Market, By End User:
o Type 1 Diabetic Patients
o Type 2 Diabetic Patients
• Global Artificial Pancreas Device System (APDS) Market, By Geography:
o North America
 U.S.
 U.S. Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 U.S. Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 U.S. Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Canada
 Canada Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Canada Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Canada Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
o Europe
 U.K.
 U.K. Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 U.K. Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 U.K. Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Germany
 Germany Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Germany Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Germany Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Italy
 Italy Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Italy Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Italy Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 France
 France Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 France Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 France Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Spain
 Spain Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Spain Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Spain Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Russia
 Russia Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Russia Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Russia Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Rest of Europe
 Rest of Europe Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Rest of Europe Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Rest of Europe Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
o Asia-Pacific
 China
 China Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 China Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 China Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 India
 India Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 India Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 India Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Japan
 Japan Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Japan Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Japan Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 ASEAN
 ASEAN Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 ASEAN Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 ASEAN Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Australia
 Australia Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Australia Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Australia Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 South Korea
 South Korea Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 South Korea Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 South Korea Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Rest of Asia Pacific (APAC)
 Rest of Asia Pacific Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Rest of Asia Pacific Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Rest of Asia Pacific Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
o Latin America
 Brazil
 Brazil Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Brazil Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Brazil Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Mexico
 Mexico Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Mexico Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Mexico Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Argentina
 Argentina Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Argentina Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Argentina Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Rest of Latin America
 Rest of Latin America Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Rest of Latin America Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Rest of Latin America Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
o Middle East
 GCC
 GCC Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 GCC Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 GCC Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Israel
 Israel Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Israel Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Israel Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Rest of Middle East
 Rest of Middle East Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Rest of Middle East Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Rest of Middle East Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
o Africa
 North Africa
 North Africa Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 North Africa Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 North Africa Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 Central Africa
 Central Africa Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 Central Africa Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 Central Africa Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
 South Africa
 South Africa Artificial Pancreas Device System (APDS) Market, By Technology:
 Threshold Suspended Device Systems
 Treat to Range/Control to Range (TTR/CTR)
 Treat to Target/ Control to Target (TTR/CTT)
 South Africa Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
 E-commerce
 Standalone Retail Shops
 Hospitals
 South Africa Artificial Pancreas Device System (APDS) Market, By End User:
 Type 1 Diabetic Patients
 Type 2 Diabetic Patients
• Company Profiles
o Medtronic*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Medtrum
o Tandem Diabetes Care, Inc.
o Johnson & Johnson
o Beta Bionics
o Bigfoot Biomedical
o Insulet Corporation
o Pancreum, Inc.
o TypeZero Technologies, Inc.
o DreaMed Diabetes Ltd
o Inreda Diabetic BV
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Technology
? Market Snippet By Distribution Channel
? Market Snippet By End User
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Supply Side Drivers
? Demand Side Drivers
? Economic Drivers
? Restraints
? Market Opportunities
? Technology Assessment
? Reimbursement and Regulatory Scenario
? Merger and Acquisitions/Collaborations
? Product Pipeline Analysis
? Pricing Analysis
4. Global Artificial Pancreas Device System (APDS) Market, By Technology, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Threshold Suspended Device Systems
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Treat to Range/Control to Range (TTR/CTR)
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Treat to Target/ Control to Target (TTR/CTT)
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
5. Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o E-Commerce
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Standalone Retail Shops
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Hospitals
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
6. Global Artificial Pancreas Device System (APDS) Market, By End User, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Type 1 Diabetic Patients
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Type 2 Diabetic Patients
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
7. Global Artificial Pancreas Device System (APDS) Market, By Regions, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, For Regions, 2014 - 2024
o North America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Canada
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Europe
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Germany
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Italy
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? France
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Russia
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Europe
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Asia Pacific
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? India
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Japan
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Australia
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Asia Pacific
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Latin America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Argentina
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Latin America
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Middle East
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Israel
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Middle East
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million))
o Africa
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
? Medtronic
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Medtrum
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
? Tandem Diabetes Care, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Johnson & Johnson
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Beta Bionics
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
? Bigfoot Biomedical
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
? Insulet Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Pancreum, Inc.
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
? TypeZero Technologies, Inc.
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
? DreaMed Diabetes Ltd
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
? Inreda Diabetic BV
? Company Overview
? Product Portfolio
? Recent Developments/Updates
? Future Plans
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Artificial Pancreas Device System (APDS) Market - Global forecast to 2024".
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us